XCUR RSI Chart
Last 7 days
-1.9%
Last 30 days
-8.9%
Last 90 days
-25%
Trailing 12 Months
-52.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2022 | 3.8M | 6.1M | 7.1M | 28.8M |
2021 | 8.4M | 3.7M | 0 | 0 |
2020 | 10.5M | 14.9M | 16.8M | 16.6M |
2019 | 107.0K | 522.0K | 992.0K | 1.3M |
2018 | 7.3M | 4.9M | 2.5M | 118.0K |
2017 | 3.2M | 5.4M | 7.5M | 9.7M |
2016 | 0 | 0 | 1.7M | 1.0M |
2015 | 0 | 0 | 0 | 2.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 29, 2024 | dgp co., ltd. | sold | -4,488,000 | 1.32 | -3,400,000 | - |
Feb 16, 2024 | miller josh | sold (taxes) | -27.4988 | 0.5978 | -46.00 | chief accounting officer |
Nov 16, 2023 | miller josh | sold (taxes) | -21.47 | 0.565 | -38.00 | chief accounting officer |
Aug 16, 2023 | miller josh | sold (taxes) | -30.71 | 0.83 | -37.00 | chief accounting officer |
Jun 23, 2023 | cbi usa, inc. | sold | -5,440,000 | 1.6 | -3,400,000 | - |
May 16, 2023 | miller josh | sold (taxes) | -198 | 1.0728 | -185 | chief accounting officer |
Dec 15, 2022 | cbi usa, inc. | bought | 5,440,000 | 1.6 | 3,400,000 | - |
May 19, 2022 | muralidhar bali | bought | 285,152 | 0.1937 | 1,472,130 | - |
Dec 21, 2021 | gates frontier, llc | sold | -303,200 | 0.239 | -1,268,620 | - |
Nov 15, 2021 | feltner douglas e. | acquired | 6,825 | 0.91 | 7,500 | chief medical officer |
Which funds bought or sold XCUR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 03, 2024 | Carlyle Group Inc. | unchanged | - | -2,872 | 160,533 | 0.01% |
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Apr 18, 2024 | NORTHWESTERN UNIVERSITY | unchanged | - | 1,000 | 31,000 | 0.03% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 14.17 | -2,019 | 23,266 | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 11,000 | 11,000 | -% |
Feb 14, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 9,706 | 9,706 | -% |
Feb 14, 2024 | MILLENNIUM MANAGEMENT LLC | new | - | 34,169 | 34,169 | -% |
Feb 14, 2024 | Royal Bank of Canada | reduced | -69.61 | - | - | -% |
Feb 14, 2024 | CITADEL ADVISORS LLC | sold off | -100 | -15,036 | - | -% |
Feb 13, 2024 | FMR LLC | sold off | -100 | -11.00 | - | -% |
Unveiling Exicure Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Exicure Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 46.4B | 6.8B | -7.77 | 6.77 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.5B | 2.0B | -58.76 | 9.74 | ||||
BMRN | 15.7B | 2.5B | 76.35 | 6.35 | ||||
INCY | 12.2B | 3.8B | 16.38 | 3.24 | ||||
MID-CAP | ||||||||
APLS | 5.3B | 524.1M | -12.77 | 10.17 | ||||
BBIO | 5.2B | 107.9M | -9.51 | 48.09 | ||||
AXSM | 3.7B | 251.0M | -12.33 | 14.56 | ||||
ARWR | 3.1B | 240.7M | -10.44 | 12.18 | ||||
ACAD | 2.8B | 726.4M | -46.38 | 3.91 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 24.99 | 4.48 | ||||
NVAX | 645.2M | 983.7M | -1.18 | 0.66 | ||||
CRBP | 424.2M | 881.7K | -12.56 | 481.06 | ||||
INO | 259.6M | 4.9M | -1.92 | 53.35 | ||||
IBIO | 7.1M | 2.1M | -0.26 | 2.14 |
Exicure Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 |
Revenue | 980.1% | 21,774,000 | 2,016,000 | 2,471,000 | 2,565,000 | 79,000 | 997,000 | 140,000 | 2,443,000 | 4,847,000 | 9,183,000 | 310,000 | 527,000 | 434,000 | 25,000 | 6,000 | 57,000 | 19,000 | 1,057,000 | 2,095,000 | 2,497,000 | 2,695,000 |
Operating Expenses | -56.0% | 3,180,000 | 7,221,000 | 9,954,000 | 10,302,000 | 13,941,000 | 13,154,000 | 12,600,000 | 11,563,000 | 9,237,000 | 8,649,000 | 10,419,000 | 6,473,000 | 5,418,000 | 5,603,000 | 4,874,000 | 5,920,000 | 5,823,000 | 5,320,000 | 5,410,000 | 4,391,000 | - |
S&GA Expenses | -12.8% | 2,107,000 | 2,416,000 | 3,205,000 | 3,162,000 | 3,098,000 | 2,892,000 | 2,728,000 | 2,424,000 | 2,229,000 | 2,574,000 | 2,152,000 | 2,228,000 | 1,985,000 | 2,208,000 | 1,866,000 | 1,919,000 | 1,988,000 | 2,045,000 | 2,947,051 | 1,270,000 | - |
R&D Expenses | -77.7% | 1,073,000 | 4,805,000 | 6,749,000 | 7,140,000 | 10,843,000 | 10,262,000 | 9,872,000 | 9,139,000 | 7,008,000 | 6,075,000 | 8,267,000 | 4,245,000 | 3,433,000 | 3,395,000 | 3,008,000 | 4,001,000 | 3,835,000 | 3,275,000 | 3,170,000 | 3,121,000 | - |
EBITDA Margin | 98.4% | -0.02 | -1.33 | -2.47 | -3.51 | -6.12 | -2.72 | -1.40 | -1.51 | -1.70 | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | 595,000 | 450,000 | 409,000 | 418,000 | 27,000 | - | 128,000 | 197,000 | 203,000 | 203,000 | 183,000 | 175,000 | 170,000 | 166,000 | 161,000 | 280,812 | 201,000 | - |
Income Taxes | - | 209,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 460.6% | 18,605,000 | -5,160,000 | -7,470,000 | -8,348,000 | -14,269,000 | -12,477,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Margin | 94.2% | -0.08 | -1.41 | -2.60 | -3.69 | -6.74 | -2.93 | -1.48 | -1.57 | -1.77 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 456.5% | 18,396,000 | -5,160,000 | -7,470,000 | -8,348,000 | -14,269,000 | -12,477,000 | -12,685,000 | -8,822,000 | -4,311,000 | 1,150,000 | -9,981,000 | -5,816,000 | -5,220,000 | -5,286,000 | -4,755,000 | -5,324,000 | -6,825,000 | -5,509,000 | -3,443,000 | -1,932,000 | - |
Net Income Margin | 93.7% | -0.09 | -1.41 | -2.60 | -3.69 | -13.19 | -4.54 | -1.48 | -1.31 | -1.28 | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -11.1% | -7,276,000 | -6,548,000 | -9,082,000 | -12,762,000 | -11,415,000 | -15,034,000 | -11,904,000 | -8,727,000 | -13,386,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -26.7% | 18.00 | 24.00 | 23.00 | 29.00 | 37.00 | 42.00 | 65.00 | 78.00 | 74.00 | 88.00 | 100 | 111 | 96.00 | 106 | 115 | 74.00 | 20.00 | 25.00 | 29.00 | 36.00 | 19.00 |
Current Assets | -67.5% | 4.00 | 11.00 | 10.00 | 17.00 | 25.00 | 29.00 | 44.00 | 64.00 | 61.00 | 74.00 | 86.00 | 97.00 | 89.00 | 102 | 113 | 72.00 | 19.00 | 24.00 | 28.00 | 34.00 | 18.00 |
Cash Equivalents | -76.6% | 2.00 | 10.00 | 9.00 | 16.00 | 22.00 | 25.00 | 44.00 | 53.00 | 44.00 | 35.00 | 34.00 | 33.00 | 18.00 | 26.00 | 48.00 | 70.00 | 17.00 | 22.00 | 26.00 | 32.00 | 16.00 |
Net PPE | -21.2% | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | -15.8% | 8.00 | 9.00 | 8.00 | 33.00 | 36.00 | 39.00 | 54.00 | 64.00 | 38.00 | 38.00 | 39.00 | 38.00 | 14.00 | 20.00 | 35.00 | 9.00 | 9.00 | 9.00 | 8.00 | 10.00 | 9.00 |
Current Liabilities | -47.6% | 1.00 | 3.00 | 2.00 | 26.00 | 20.00 | 21.00 | 34.00 | 22.00 | 13.00 | 13.00 | 14.00 | 13.00 | 14.00 | 20.00 | 31.00 | 8.00 | 8.00 | 8.00 | 2.00 | 9.00 | 4.00 |
Long Term Debt | - | - | - | - | - | - | - | - | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | - | - | - | - | - | - | 5.00 | - | 3.00 |
LT Debt, Current | - | - | - | - | - | - | - | 7.00 | - | - | - | - | - | - | - | 5.00 | 5.00 | 5.00 | 5.00 | - | 5.00 | 2.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | - | - | - | - | - | - | 5.00 | - | 3.00 |
Shareholder's Equity | -33.6% | 10.00 | 15.00 | 15.00 | - | 1.00 | 3.00 | 11.00 | 14.00 | 37.00 | 50.00 | 62.00 | 73.00 | 82.00 | 85.00 | 81.00 | 65.00 | 11.00 | 16.00 | 21.00 | 25.00 | 10.00 |
Retained Earnings | -3.3% | -182 | -177 | -172 | -191 | -185 | -178 | -170 | -156 | -132 | -118 | -105 | -93.28 | -84.46 | -80.15 | -81.30 | -71.32 | -65.50 | -60.28 | -54.99 | -50.24 | -44.91 |
Additional Paid-In Capital | 0.4% | 193 | 192 | 188 | 187 | 187 | 182 | 181 | 170 | 169 | 168 | 167 | 166 | 166 | 165 | 162 | 136 | 77.00 | 76.00 | 76.00 | 75.00 | 55.00 |
Shares Outstanding | 3.3% | 9.00 | 8.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | 9.00 | - | - | - | 115 | - | - | - | 128 | - | - | - | 72.00 | - | - | - | 118 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -45.0% | -4,811 | -3,318 | -7,276 | -6,548 | -9,078 | -12,756 | -13,797 | 4,863 | -11,076 | -14,809 | -11,807 | -8,649 | -10,967 | -7,847 | 15,330 | -5,017 | -4,984 | -4,012 | -5,963 | -4,193 | -4,684 |
Share Based Compensation | 214.6% | 969 | 308 | 228 | 292 | 507 | 342 | 769 | 889 | 764 | 517 | 581 | 618 | 544 | 441 | 401 | 511 | 439 | 489 | 509 | 516 | 419 |
Cashflow From Investing | -1887.7% | -1,895 | 106 | 207 | 998 | 1,496 | 1,995 | 4,108 | 4,444 | 19,236 | 15,297 | 13,472 | 5,635 | 3,538 | -12,503 | -62,970 | -400 | -54.00 | -8.00 | -29.00 | -5.00 | -60.00 |
Cashflow From Financing | -120.0% | -919 | 4,595 | - | -2.00 | 4,890 | -7,993 | 448 | -9.00 | 131 | 546 | 138 | 17,275 | 50.00 | -2,333 | 25,708 | 58,634 | 17.00 | -52.00 | -186 | 20,264 | - |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Collaboration revenue | $ 0 | $ 2,471,000 | $ 0 | $ 5,036,000 |
Total revenue | 0 | 2,471,000 | 0 | 5,036,000 |
Operating expenses: | ||||
Research and development expense | 921,000 | 6,749,000 | 2,902,000 | 13,889,000 |
General and administrative expense | 4,721,000 | 3,205,000 | 7,279,000 | 6,367,000 |
Total operating expenses | 5,642,000 | 9,954,000 | 10,181,000 | 20,256,000 |
Operating loss | (5,642,000) | (7,483,000) | (10,181,000) | (15,220,000) |
Other income (expense), net: | ||||
Dividend income | 15,000 | 16,000 | 32,000 | 18,000 |
Interest income | 13,000 | 1,000 | 24,000 | 3,000 |
Interest expense | 0 | 0 | 0 | (595,000) |
Other income (expense), net | (150,000) | (4,000) | (46,000) | (24,000) |
Total other income (expense), net | (122,000) | 13,000 | 10,000 | (598,000) |
Net loss before provision for income taxes | (5,764,000) | (7,470,000) | (10,171,000) | (15,818,000) |
Provision for income taxes | 0 | 0 | 0 | 0 |
Net loss | $ (5,764,000) | $ (7,470,000) | $ (10,171,000) | $ (15,818,000) |
Basic loss per common share (in dollars per share) | $ (0.68) | $ (1.66) | $ (1.38) | $ (3.71) |
Diluted loss per common share (in dollars per share) | $ (0.68) | $ (1.66) | $ (1.38) | $ (3.71) |
Weighted-average basic common shares outstanding (in shares) | 8,432,394 | 4,503,983 | 7,366,594 | 4,268,955 |
Weighted-average diluted common shares outstanding (in shares) | 8,432,394 | 4,503,983 | 7,366,594 | 4,268,955 |
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,335 | $ 8,577 |
Prepaid expenses and other assets | 1,329 | 1,474 |
Total current assets | 3,664 | 10,051 |
Property and equipment, net | 1,796 | 2,530 |
Right-of-use asset | 6,893 | 7,257 |
Other noncurrent assets | 5,202 | 3,490 |
Total assets | 17,555 | 23,328 |
Current liabilities: | ||
Accounts payable | 343 | 361 |
Accrued expenses and other current liabilities | 1,088 | 1,278 |
Total current liabilities | 1,431 | 1,639 |
Lease liability, noncurrent | 6,419 | 6,767 |
Total liabilities | 7,850 | 8,406 |
Contingencies (Note 11) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized, no shares issued and outstanding, June 30, 2023 and December 31, 2022 | 0 | 0 |
Common stock, $0.0001 par value per share; 200,000,000 shares authorized, 8,648,307 issued and outstanding, June 30, 2023; 4,965,901 issued and outstanding, December 31, 2022 | 1 | 0 |
Additional paid-in capital | 192,524 | 187,571 |
Accumulated deficit | (182,820) | (172,649) |
Total stockholders’ equity | 9,705 | 14,922 |
Total liabilities and stockholders’ equity | $ 17,555 | $ 23,328 |